12/25/2023 0 Comments Chest pain covid vaccine side effectAround half were admitted to hospital, including 11 who were treated in intensive care. Importantly, the TGA states that while the rates contained in the table include cases of likely myocarditis that occurred after vaccination, they may not necessarily be vaccine-related and are still lower than myocarditis rates in people infected with COVID-19.Īdditionally, the number of younger people vaccinated is still relatively low in Australia, so estimated reporting rates are based on limited data.Īccording to the TGA, of the cases classified as likely myocarditis, most patients experienced symptoms within three days of vaccination. Both of the 12–17 age group figures are an increase on the rates contained in the most previous TGA safety report (5.2 and 7.1 cases per 100,000 first and second doses, respectively). The table shows suspected myocarditis following a second dose of Pfizer occurs at a rate of 8.5 cases per 100,000 in boys aged 12–17, more than three times higher than the overall rate among all males of 2.7 per 100,000.īoys aged 12–17 are also more than twice as likely to develop suspected myocarditis following a first Pfizer dose (5.6 per 100,000) than the general male population. Rates of myocarditis cases following Pfizer However, it has provided the below table in relation Pfizer, which breaks down the rates between age groups and sexes. The relatively low number of Moderna doses administered in Australia to date means the TGA is unable to provide a reliable estimated rate of myocarditis following vaccination. The youngest case classified as likely myocarditis to date was 12 years old.īeing infected with COVID-19 itself is ‘associated with a substantially higher risk of myocarditis and other cardiac complications compared to the COVID vaccines’. The updated figures, current as of 14 November, mean there have been 329 reports of likely myocarditis from approximately 23.4 million doses of Pfizer and 978,000 Moderna doses.Ī further 592 cases have been identified as ‘suspected myocarditis’, including 116 in children aged 12–17, while there have been 1370 cases of suspected pericarditis only. But if I willingly put something in my body which can cause me harm, I’ll never be able to forgive myself.’īut according to the Therapeutic Goods Administration’s (TGA) latest safety report, the likelihood of developing myocarditis or pericarditis after an mRNA vaccine remains exceedingly rare.Īustralia recorded only 28 new cases deemed ‘likely myocarditis’ following mRNA vaccination over the previous week, 10 fewer than the prior seven days, the report found. ‘To me COVID doesn’t present a real danger to my life because I’m a healthy individual, I take care of myself,’ he told Nine Newspapers. Melbourne’s Sumit Aneja is concerned after someone he knows who had never previously had heart problems developed pericarditis following a vaccine. It is a common refrain among Australians who are still reluctant to receive a COVID vaccine, whether due to the extremely rare possibility of blood clots with AstraZeneca, or myocarditis and pericarditis with Pfizer or Moderna.Īs fewer doses of AstraZeneca are administered in the latter stages of Australia’s vaccine rollout, hesitant people are increasingly expressing concerns over the mRNA options. This article was updated at 5.50 pm Monday 22 November. As many of Australia’s remaining vaccine-hesitant patients express concerns over rare side effects associated with mRNA vaccines, the TGA has broken down rates of myocarditis cases following Pfizer doses.īoys aged 12–17 are more likely to develop myocarditis following their second Pfizer dose.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |